China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes
Status: Recruiting
Location: See all (11) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY
The aim of the China Diabetes Type 1 Study (CD1S) is to conduct a nationwide type 1 diabetes (T1D) registry study in patients with T1D and in pediatric adolescent patients with diabetes who had an age of onset \<= 20 years. CD1S compromises a retrospective study enrolling inpatients hospitalized from Jan 1st, 2016 to Dec 31, 2021, and a prospective study beginning from the year 2022.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• 1\. Patients with type 1 diabetes mellitus of any duration; meeting criteria (1) or any of (2) or any of (3)
‣ Clinical diagnosis of type 1 diabetes by a specialist
⁃ Age at onset \< 15 years; no overweight or obesity at onset; previous diabetic ketoacidosis; highest random C-peptide \< 200 pmol/L
⁃ Initiation and continuation of insulin therapy (except pancreatic or islet transplantation) after diagnosis; positive islet autoantibodies Or 2. Children and adolescents with diabetes mellitus at age of onset \<= 20 years, regardless of type and duration of disease.
Locations
Other Locations
China
The Second Xiangya Hospital, Central South University
RECRUITING
Changsha
Heji Hospital Affiliated to Changzhi Medical College
RECRUITING
Changzhi
Hainan General Hospital
RECRUITING
Haikou
Zhejiang Provincial People's Hospital
RECRUITING
Hangzhou
the First Affiliated Hospital of Harbin Medical University
RECRUITING
Harbin
The First People's Hospital of Yunnan
RECRUITING
Kunming
Gansu Provincial People's Hospital
RECRUITING
Lanzhou
The First Affiliated Hospital of Henan University of Science and Technology
RECRUITING
Luoyang
The First Affiliated Hospital of Nanjing Medical University
NOT_YET_RECRUITING
Nanjing
Shenzhen Second People's Hospital
RECRUITING
Shenzhen
The First Affiliated Hospital of Xinjiang Medical University
RECRUITING
Ürümqi
Contact Information
Primary
Zhiguang Zhou, MD, PhD
zhouzhiguang@csu.edu.cn
+8673185292154
Backup
Xia Li, MD, PhD
lixia@csu.edu.cn
Time Frame
Start Date:2022-01-01
Estimated Completion Date:2035-12-31
Participants
Target number of participants:20000
Treatments
Individuals diagnosed with type 1 diabetes
All patients diagnosed with type 1 diabetes of all ages.
Individuals with diabetes who had an age of onset <= 20 years.
All patients with diabetes who had an age of onset \<= 20 years.